Physician profile
Helen Shnol
NPI 1295258366
$22,226.14
in general payments reported to CMS, 2019-2025
18 companies · $3,915 in 2025
The $3,915 reported for 2025 was more than what 97% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,573 · 2020: $1,064 · 2021: $13K · 2022: $1,412 · 2023: $334 · 2024: $722 · 2025: $3,915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,373 · Food and Beverage: $2,062 · Long Term Medical Supply Or Device Loan: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,372.62 |
| Food and Beverage | $2,062.29 |
| Long Term Medical Supply Or Device Loan | $536.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Summit Surgical Corp. | $7,566.80 | 2021 | |
| Arthrex, INC. | $4,505.25 | 2021 | |
| Smith+Nephew, INC. | $2,027.28 | 2025 | Pico, Collagenase Santyl, Versajet |
| Treace Medical Concepts, INC. | $1,979.15 | 2020-2021 | |
| Medline Industries Lp | $1,443.19 | 2022-2025 | |
| Paragon 28, INC. | $1,201.66 | 2021-2025 | Portfolio, Monkey Rings |
| Organogenesis INC. | $975.85 | 2019-2025 | Apligraf |
| Integra Lifesciences Corporation | $701.38 | 2019-2025 | Cytal, Micromatrix |
| Kerecis Limited | $547.46 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Stryker Corporation | $413.32 | 2019 | |
| Amgen INC. | $275.00 | 2024-2025 | Krystexxa |
| Micromed INC | $147.48 | 2021 | |
| Horizon Therapeutics Plc | $124.98 | 2023 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $108.03 | 2019 | |
| Saxum Surgical, INC. | $64.67 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $56.26 | 2025 | Nuzyra |
| Next Science LLC | $48.92 | 2023 | Surgx, Blastx, Xperience |
| Solventum Corporation | $39.46 | 2025 | V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Shnol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.